Navigation Links
Robbins & Myers To Release First Quarter Fiscal 2010 Financial Results
Date:12/15/2009

DAYTON, Ohio, Dec. 15 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that it will release results for its fiscal 2010 first quarter ending November 30, 2009, before the market opens on Wednesday, January 6, 2010. A live webcast is scheduled for Wednesday, January 6, 2010, at 2:30 p.m., ET. Peter C. Wallace, President and Chief Executive Officer, and Christopher M. Hix, Vice President and Chief Financial Officer, will be discussing the Company's performance and responding to questions from the financial community.

Investors may listen to the call on its website, www.robn.com, or access the conference call in the U.S./Canada, by dialing 1-866-700-0161 with conference ID #86054479. The international dial in number is +1-617-213-8832 with the same conference ID number. A replay will be available at the website and a telephonic replay will be accessible beginning 5:30 p.m. ET, January 6, by dialing 1-888-286-8010 in the U.S. and entering conference ID #85472549. For those outside the U.S., the international replay number is +1-617-801-6888 with the same ID number.

Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.

SOURCE Robbins & Myers, Inc.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
2. Robbins & Myers Announces Regular Quarterly Cash Dividend
3. Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award
4. Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8
5. Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014
6. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
7. Vivakor Announces Launch of VivaThermic Website and Highlights Distribution & Sales of Its VivaThermic Products in Japan Through Veritas Corporation
8. Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications
9. Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy
10. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
11. Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market, Says Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification ... pleased to announce the launch of the GFCP Scoop in response ... The purpose of the GFCP Scoop site is to keep the ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
(Date:4/29/2016)... GA (PRWEB) , ... April 29, 2016 , ... ... the closing of a growth round of funding led by Eastside Partners, with ... support the company’s rapidly growing customer base and accelerate its technology and product ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... focused entirely on patients with cancer, today announced that Lynne Malestic, RN, of ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
Breaking Medicine News(10 mins):